Inspection Record

KDC/One Development Corporation Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-11-14 12 findingsValidation and qualificationMaterial and supplier controlComputer system validationEquipment and facilityCleaning validationTraining and personnelDeviation, CAPA, and investigationLaboratory and QC controls

View the regulator's official source The source document is always the basis for judgement.

Findings

1Validation and qualification

The qualification and/or verification of utilities and/or support systems was inadequate.

2Material and supplier control

The protection of products and/or materials from contamination was inadequate.

3Material and supplier control

The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.

4Computer system validation

The creation, maintenance, processing, and/or review of laboratory data was inadequate. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

5Equipment and facility

The maintenance of records was inadequate.

6Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

7Material and supplier control

The drug fabricator's specifications for raw materials were inadequate.

8Cleaning validation

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate. The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

9Training and personnel

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

10Equipment and facility

The preventative maintenance and repair of the equipment was inadequate. The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material.

11Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

12Laboratory and QC controls

The quality control department did not undertake all of the required activities.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-11-14. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

KDC/One Development Corporation Inc. company profile — full history Health Canada documents, 2022 Go to Findings search